Repository logo
 
Publication

Ablation Strategies for Different Types of Atrial Fibrillation in Europe: Results of the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term Registry

2020Journal article Open access
Simple item page
dc.contributor.authorSchmidt, B
dc.contributor.authorBrugada, J
dc.contributor.authorArbelo, E
dc.contributor.authorLaroche, C
dc.contributor.authorBayramova, S
dc.contributor.authorBertini, M
dc.contributor.authorLetsas, K
dc.contributor.authorPison, L
dc.contributor.authorRomanov, A
dc.contributor.authorScherr, D
dc.contributor.authorTilz, R
dc.contributor.authorMaggioni, A
dc.contributor.authorAdragao, P
dc.contributor.authorLund, J
dc.contributor.authorHaman, L
dc.contributor.authorOliveira, MM
dc.contributor.authorDagres, N
dc.date.accessioned2021-04-21T14:34:30Z
dc.date.available2021-04-21T14:34:30Z
dc.date.issued2020
dc.description.abstractAims: The ESC EORP EHRA Atrial Fibrillation (AF) Ablation Long-Term registry was designed to assess management and outcomes of AF catheter ablation procedures in Europe. To investigate the current ablation approaches and their outcomes for patients with paroxymal AF (PAF) and non-PAF in Europe. Methods and results: Data from index ablations were collected in 27 European countries at 104 centres in a prospective fashion. Pre-procedural, procedural, and 1-year follow-up data were captured on a web-based electronic case record form. Data on the ablation procedure were available for 3446 patients. Of these, 2513 patients and 933 patients underwent pulmonary vein isolation (PVI) or PVI plus (PVIplus) additional ablation, respectively. The ablation strategy was limited to PVI in 81% and 56% of patients in the PAF and non-PAF group, respectively (P < 0.001). In the non-PAF group, left atrial linear ablation and ablation of complex fragmented atrial electrograms were more commonly performed. Arrhythmias recurrence after PVI was 29% and 39% in the PAF and non-PAF group, respectively (P < 0.001) and 42% after PVIplus in both groups. Atrial fibrillation related hospital admissions were more common in the PVIplus group (20% vs. 14%). A very low procedural complication rate was observed. No relevant differences were observed with regard to repeat ablation (PVI 9% and PVIplus 11%). Conclusion: In patients with PAF and non-PAF, the ablation strategies of PVI and PVIplus led to similar arrhythmia-free survival rates after 1 year. A considerable hospital readmission rate was noted.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEuropace. 2020 Apr 1;22(4):558-566.pt_PT
dc.identifier.doi10.1093/europace/euz318pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/3667
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Society of Cardiologypt_PT
dc.subjectHSM CARpt_PT
dc.subjectAtrial Fibrillation* / diagnosispt_PT
dc.subjectEuropept_PT
dc.subjectHumanspt_PT
dc.subjectAtrial Fibrillation* / surgerypt_PT
dc.subjectProspective Studies
dc.subjectCatheter Ablation*
dc.subjectPulmonary Veins* / surgery
dc.subjectRecurrence
dc.subjectRegistries
dc.subjectTreatment Outcome
dc.titleAblation Strategies for Different Types of Atrial Fibrillation in Europe: Results of the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term Registrypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage566pt_PT
oaire.citation.issue4pt_PT
oaire.citation.startPage558pt_PT
oaire.citation.titleEuropace: European Pacing, Arrhythmias, and Cardiac Electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiologypt_PT
oaire.citation.volume22pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Europace 2019 ablation.pdf
Size:
480.44 KB
Format:
Adobe Portable Document Format
Download

Collections

CAR - Artigos